India · Delayed Price · Currency is INR Aurobindo Pharma Statistics
Total Valuation
NSE:AUROPHARMA has a market cap or net worth of INR 652.70 billion. The enterprise value is 641.65 billion.
| Market Cap | 652.70B |
| Enterprise Value | 641.65B |
Important Dates
The last earnings date was Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Aug 8, 2025 |
Share Statistics
NSE:AUROPHARMA has 580.80 million shares outstanding. The number of shares has decreased by -0.58% in one year.
| Current Share Class | 580.80M |
| Shares Outstanding | 580.80M |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 15.25% |
| Owned by Institutions (%) | 51.34% |
| Float | 278.75M |
Valuation Ratios
The trailing PE ratio is 19.07 and the forward PE ratio is 16.30. NSE:AUROPHARMA's PEG ratio is 1.35.
| PE Ratio | 19.07 |
| Forward PE | 16.30 |
| PS Ratio | 2.01 |
| PB Ratio | 1.86 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | 18.01 |
| P/OCF Ratio | 10.60 |
| PEG Ratio | 1.35 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.76, with an EV/FCF ratio of 17.71.
| EV / Earnings | 18.75 |
| EV / Sales | 1.97 |
| EV / EBITDA | 9.76 |
| EV / EBIT | 12.81 |
| EV / FCF | 17.71 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.85 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.18 |
| Debt / FCF | 2.15 |
| Interest Coverage | 12.29 |
Financial Efficiency
Return on equity (ROE) is 10.38% and return on invested capital (ROIC) is 7.66%.
| Return on Equity (ROE) | 10.38% |
| Return on Assets (ROA) | 6.25% |
| Return on Invested Capital (ROIC) | 7.66% |
| Return on Capital Employed (ROCE) | 13.59% |
| Revenue Per Employee | 11.74M |
| Profits Per Employee | 1.24M |
| Employee Count | 27,707 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.27 |
Taxes
In the past 12 months, NSE:AUROPHARMA has paid 15.97 billion in taxes.
| Income Tax | 15.97B |
| Effective Tax Rate | 31.83% |
Stock Price Statistics
The stock price has decreased by -19.43% in the last 52 weeks. The beta is 0.09, so NSE:AUROPHARMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -19.43% |
| 50-Day Moving Average | 1,091.64 |
| 200-Day Moving Average | 1,131.52 |
| Relative Strength Index (RSI) | 53.78 |
| Average Volume (20 Days) | 1,447,417 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AUROPHARMA had revenue of INR 325.14 billion and earned 34.22 billion in profits. Earnings per share was 58.93.
| Revenue | 325.14B |
| Gross Profit | 187.35B |
| Operating Income | 50.35B |
| Pretax Income | 50.18B |
| Net Income | 34.22B |
| EBITDA | 65.32B |
| EBIT | 50.35B |
| Earnings Per Share (EPS) | 58.93 |
Balance Sheet
The company has 88.92 billion in cash and 77.95 billion in debt, giving a net cash position of 10.98 billion or 18.90 per share.
| Cash & Cash Equivalents | 88.92B |
| Total Debt | 77.95B |
| Net Cash | 10.98B |
| Net Cash Per Share | 18.90 |
| Equity (Book Value) | 350.34B |
| Book Value Per Share | 603.40 |
| Working Capital | 131.48B |
Cash Flow
In the last 12 months, operating cash flow was 61.57 billion and capital expenditures -25.34 billion, giving a free cash flow of 36.23 billion.
| Operating Cash Flow | 61.57B |
| Capital Expenditures | -25.34B |
| Free Cash Flow | 36.23B |
| FCF Per Share | 62.38 |
Margins
Gross margin is 57.62%, with operating and profit margins of 15.48% and 10.53%.
| Gross Margin | 57.62% |
| Operating Margin | 15.48% |
| Pretax Margin | 15.43% |
| Profit Margin | 10.53% |
| EBITDA Margin | 20.09% |
| EBIT Margin | 15.48% |
| FCF Margin | 11.14% |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.71%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 0.71% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.79% |
| Buyback Yield | 0.58% |
| Shareholder Yield | 1.29% |
| Earnings Yield | 5.24% |
| FCF Yield | 5.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jul 20, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |